{"content":"<li class=\"n-box-item date-title\" data-end=\"1488603599\" data-start=\"1488517200\" data-txt=\"Sunday, December 22, 2019\">Friday, March  3, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3248679\" data-ts=\"1488585472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248679-sprint-awarded-139_8m-jury-finds-twc-infringed-voip-patents\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint awarded $139.8M as jury finds TWC infringed VoIP patents</a></h4><ul>    <li>Sprint (<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a> <font color='green'>+2%</font>) has <a href=\"https://www.bloomberg.com/news/articles/2017-03-03/sprint-wins-139-8-million-in-time-warner-cable-patent-trial\" target=\"_blank\">won at least $139.8M in damages</a> in a trial where a jury found Time Warner Cable (<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a> <font color='red'>-0.5%</font>) infringed digital voice phone service patents.</li>    <li>The jury decided that TWC willfully infringed on Sprint's VoIP patents, which means damages could be trebled by the judge.</li>    <li>Sprint had filed its action in 2011.</li>    <li>The wireless carrier also has a similar action against Comcast (<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='red'>-0.6%</font>) set to come before the same Kansas City judge next week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248679\" data-linked=\"Sprint awarded $139.8M as jury finds TWC infringed VoIP patents\" data-tweet=\"$S $S $CHTR - Sprint awarded $139.8M as jury finds TWC infringed VoIP patents https://seekingalpha.com/news/3248679-sprint-awarded-139_8m-jury-finds-twc-infringed-voip-patents?source=tweet\" data-url=\"https://seekingalpha.com/news/3248679-sprint-awarded-139_8m-jury-finds-twc-infringed-voip-patents\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>102&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248671\" data-ts=\"1488581012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248671-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/NOVN' title='Novan'>NOVN</a> <font color='green'>+4.7%</font>. <a href='https://seekingalpha.com/symbol/GRAM-OLD' title='Graña y Montero'>GRAM-OLD</a> <font color='green'>+3.8%</font>. <a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a> <font color='green'>+3.3%</font>. <a href='https://seekingalpha.com/symbol/DFIN' title='Donnelley Financial Solutions, Inc.'>DFIN</a> <font color='green'>+2.0%</font>. <a href='https://seekingalpha.com/symbol/UCTT' title='Ultra Clean Holdings, Inc.'>UCTT</a> <font color='green'>+2.0%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color='red'>-4.4%</font>. <a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a> <font color='red'>-2.9%</font>. <a href='https://seekingalpha.com/symbol/AGI' title='Alamos Gold Inc'>AGI</a> <font color='red'>-2.4%</font>. <a href='https://seekingalpha.com/symbol/FSM' title='Fortuna Silver Mines'>FSM</a> <font color='red'>-2.4%</font>. <a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc'>PVG</a> <font color='red'>-2.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248671\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$NOVN $GRAM-OLD $ECYT - After Hours Gainers / Losers https://seekingalpha.com/news/3248671-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3248671-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248663\" data-ts=\"1488579260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248663-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/XHB' title='SPDR Homebuilders ETF'>XHB</a> <font color='green'>+2.6%</font>. <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='green'>+2.3%</font>. <a href='https://seekingalpha.com/symbol/IYH' title='iShares U.S. Healthcare ETF'>IYH</a> <font color='green'>+1.5%</font>. <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='green'>+1.4%</font>. <a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a> <font color='green'>+1.4%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a> <font color='red'>-11.4%</font>. <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a> <font color='red'>-8.0%</font>. <a href='https://seekingalpha.com/symbol/URA' title='Global X Uranium ETF'>URA</a> <font color='red'>-4.5%</font>. <a href='https://seekingalpha.com/symbol/REMX' title='VanEck Vectors Rare Earth/Strategic Metals ETF'>REMX</a> <font color='red'>-4.0%</font>. <a href='https://seekingalpha.com/symbol/TAN' title='Guggenheim Solar ETF'>TAN</a> <font color='red'>-3.7%.</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3248663\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$XHB $XLF $IYH - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3248663-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3248663-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248662\" data-ts=\"1488578464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248662-chipotle-files-2_88m-share-shelf-for-pershing-square\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle files 2.88M share shelf for Pershing Square</a></h4><ul><li>That represents all of Pershing Square's holdings and 10% of the total float of Chipotle (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>). The timing and amount of actual sales (if any) by Ackman is a story to be told.</li><li><a href=\"https://seekingalpha.com/filing/3444745\" target=\"_blank\">SEC Form S-3</a></li><li>Shares&nbsp;<font color='red'>-0.55%</font>&nbsp;after hours</li><li>Update: In <a href=\"https://seekingalpha.com/filing/3444898\" target=\"_blank\">a 13D</a> filed alongside the shelf registration, Pershing Square says it has no current plans to sell any shares in CMG.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248662\" data-linked=\"Chipotle files 2.88M share shelf for Pershing Square\" data-tweet=\"$CMG - Chipotle files 2.88M share shelf for Pershing Square https://seekingalpha.com/news/3248662-chipotle-files-2_88m-share-shelf-for-pershing-square?source=tweet\" data-url=\"https://seekingalpha.com/news/3248662-chipotle-files-2_88m-share-shelf-for-pershing-square\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248644\" data-ts=\"1488574899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPP\" target=\"_blank\">WPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248644-wppminus-7_7-sees-tougher-2017-after-record-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WPP -7.7% as its sees tougher 2017 after record year</a></h4><ul>   <li>WPP (WPPGY) beat estimates with its <a href=\"https://seekingalpha.com/news/3248438-wpp-plc-reports-fy-results\" target=\"_blank\">2016 revenues</a>, but notes that 2017 is off to a relatively slower start.</li>    <li>Shares are <font color='red'>off 7.7%</font> in U.S. trading.</li>    <li>Last year was another record, the ad giant notes. Revenue was up 17.6%; reported billings were up 16% (up 5.5% in constant currency) to &pound;55.245B.</li>    <li>Headline EBITDA rose 20.8% to &pound;2.42B, beating an expected &pound;2.34B.</li>    <li>January revenue (like-for-like) was up 1.5% and net sales up 1.2% against tougher comps.</li>    <li>Net debt as of Dec. 31 was &pound;4.131B, up &pound;920M Y/Y.</li>    <li>\"Given continued tepid economic growth and recent weaker comparative net new business trends,\" budgets for 2017 are set \"conservatively\" at 2% for both revenue and net sales, with a headline operating margin target improvement on net sales of 0.3 points (constant currency).</li>    <li><a href=\"https://seekingalpha.com/pr/16760592-wpp-2016-preliminary-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3248644\" data-linked=\"WPP -7.7% as its sees tougher 2017 after record year\" data-tweet=\"$WPP - WPP -7.7% as its sees tougher 2017 after record year https://seekingalpha.com/news/3248644-wppminus-7_7-sees-tougher-2017-after-record-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3248644-wppminus-7_7-sees-tougher-2017-after-record-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248641\" data-ts=\"1488574774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEM\" target=\"_blank\">NEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248641-newmont-mining-maintained-outperform-credit-suisse-pt-trimmed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newmont Mining maintained Outperform at Credit Suisse but PT trimmed</a></h4><ul><li>Newmont Mining (<a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation &#40;Holding Company&#41;'>NEM</a> <font color='green'>+1.5%</font>) has shed 7% in the past month but Credit Suisse nevertheless maintains its <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/03/03/newmont-mining-down-it-goes/\" target=\"_blank\">Outperform rating</a> on the shares, citing its cash flow stability, solid exploration track record and strategic focus on free cash flow growth.</li><li>Credit Suisse says NEM boasts the strongest balance sheet of its peers and has highlighted its organic project pipeline as its first capital allocation priority, followed by returning cash to shareholders.</li><li>Modeling NEM's <a href=\"https://seekingalpha.com/news/3245068-newmont-mining-sees-higher-2017minus-18-gold-costs-maintains-production-view\" target=\"_blank\">recent guidance</a>, the firm drops its stock price target to $47 from $51 due to a 4% lower net asset value to $24.27/share from $25.39 and 13% lower 2017 operating cash flow to $2.58/share from $2.96.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248641\" data-linked=\"Newmont Mining maintained Outperform at Credit Suisse but PT trimmed\" data-tweet=\"$NEM - Newmont Mining maintained Outperform at Credit Suisse but PT trimmed https://seekingalpha.com/news/3248641-newmont-mining-maintained-outperform-credit-suisse-pt-trimmed?source=tweet\" data-url=\"https://seekingalpha.com/news/3248641-newmont-mining-maintained-outperform-credit-suisse-pt-trimmed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248637\" data-ts=\"1488574259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIT\" target=\"_blank\">XBIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248637-xbiotech-commences-direct-offering-of-common-stock-13-shares-up-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XBiotech commences direct offering of common stock at $13; shares up 7%</a></h4><ul><li>Thinly traded micro cap XBiotech (<a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='green'>+7.3%</font>) heads north on a 33% higher volume on the heels of its <a href=\"https://seekingalpha.com/pr/16760810-xbiotech-announces-registered-direct-offering-common-shares\" target=\"_blank\">announcement </a>of a $31M direct offering of common stock at $13 per share. Closing date is March 8.</li><li>Net proceeds will fund the continued development of its pipeline, commercialization expenses after approvals, manufacturing and general corporate purposes.</li><li>Shares are currently exchanging hands at slightly less than $15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248637\" data-linked=\"XBiotech commences direct offering of common stock at $13; shares up 7%\" data-tweet=\"$XBIT - XBiotech commences direct offering of common stock at $13; shares up 7% https://seekingalpha.com/news/3248637-xbiotech-commences-direct-offering-of-common-stock-13-shares-up-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3248637-xbiotech-commences-direct-offering-of-common-stock-13-shares-up-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248636\" data-ts=\"1488574025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNI\" target=\"_blank\">CNI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248636-canadian-national-rail-upgraded-scotiabank-q1-volumes-start-strong\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian National Rail upgraded at Scotiabank as Q1 volumes start strong</a></h4><ul><li>Canadian National Railway (<a href='https://seekingalpha.com/symbol/CNI' title='Canadian National Railway Company'>CNI</a> <font color='green'>+1.5%</font>) has moved steadily higher through the day as Scotiabank <a href=\"https://twitter.com/amberkanwar/status/837633940559171584\" target=\"_blank\">upgrades</a> shares to Outperform with a C$105 price target.</li><li>Scotia says most investors already expect CNI to beat its guidance, but the firm thinks results are likely to wind up higher than currently reflected.</li><li>CNI's Q1 volume are coming in well ahead of estimates, and the firm sees few risks to the top line in 2017, as many product groups are outperforming expectations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248636\" data-linked=\"Canadian National Rail upgraded at Scotiabank as Q1 volumes start strong\" data-tweet=\"$CNI - Canadian National Rail upgraded at Scotiabank as Q1 volumes start strong https://seekingalpha.com/news/3248636-canadian-national-rail-upgraded-scotiabank-q1-volumes-start-strong?source=tweet\" data-url=\"https://seekingalpha.com/news/3248636-canadian-national-rail-upgraded-scotiabank-q1-volumes-start-strong\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248635\" data-ts=\"1488573907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORV\" target=\"_blank\">CORV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248635-cardiome-launches-antibiotic-xydalba-in-france-shares-ahead-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cardiome launches antibiotic XYDALBA in France; shares ahead 3%</a></h4><ul><li>Thinly traded nano cap Cardiome (CRME <font color='green'>+3%</font>) perks up on almost 2 1/2 times normal volume, albeit on turnover of only 90K shares, on the heels of its <a href=\"https://seekingalpha.com/pr/16760669-cardiome-announces-commercial-launch-xydalba-dalbavancin-france\" target=\"_blank\">announcement </a>that its has launched XYDALBA (dalbavacin) in France after receiving authorization from the French Transparency Pricing Commission. It is indicated for the treatment of acute bacterial skin and skin structure infections ((ABSSSI)) in adults.</li><li>SVP Commercial Hugues Sachot says, \"We are extremely pleased with the progress we've made to date in launching XYDALBA across our licensed territories in Germany, the UK and now France. We've expanded our resources and commercial infrastructure across our European direct sales markets in support of a successful launch and our efforts are paying off by launching on schedule and building excitement around this product within the infectious disease community.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3248635\" data-linked=\"Cardiome launches antibiotic XYDALBA in France; shares ahead 3%\" data-tweet=\"$CORV - Cardiome launches antibiotic XYDALBA in France; shares ahead 3% https://seekingalpha.com/news/3248635-cardiome-launches-antibiotic-xydalba-in-france-shares-ahead-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3248635-cardiome-launches-antibiotic-xydalba-in-france-shares-ahead-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248632\" data-ts=\"1488573133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMS\" target=\"_blank\">SGMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248632-scientific-gamesplus-8_6-after-big-progress-on-expenses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scientific Games +8.6% after big progress on expenses</a></h4><ul><li>Alongside Q4 results reported last night, Scientific Games (<a href='https://seekingalpha.com/symbol/SGMS' title='Scientific Games Corp'>SGMS</a> <font color='green'>+8.4%</font>) disclosed the closing of financing deals which will save about $30M per year in interest costs, extend a sizable portion of maturities into 2021 and 2022, and cut exposure to variable interest rates.</li><li>Newish CEO Kevin Sheehan \"has hit the ground running,\" says Stifel's&nbsp;Steven Wieczynski, noting the successful implementation of a $75M cost-savings plan, and the identification of opportunities to improve go-to-market strategies (and the above-mentioned refinance).</li><li>Sheehan retains his Hold rating, and lifts the PT to $22 from $19.</li><li>Source: Bloomberg</li><li><a href='https://seekingalpha.com/symbol/SGMS' title='Scientific Games Corp'>SGMS</a>&nbsp;<font color='green'>+8.6%</font>&nbsp;to $22.70.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3248298-scientific-games-misses-0_34-beats-revenue\" target=\"_blank\">Scientific Games misses by $0.34, beats on revenue</a> (March 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248632\" data-linked=\"Scientific Games +8.6% after big progress on expenses\" data-tweet=\"$SGMS - Scientific Games +8.6% after big progress on expenses https://seekingalpha.com/news/3248632-scientific-gamesplus-8_6-after-big-progress-on-expenses?source=tweet\" data-url=\"https://seekingalpha.com/news/3248632-scientific-gamesplus-8_6-after-big-progress-on-expenses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248630\" data-ts=\"1488572699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248630-cliffs-outlook-gets-bump-from-credit-suisse-on-higher-iron-ore-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cliffs outlook gets bump from Credit Suisse on higher iron ore prices</a></h4><ul><li>Credit Suisse lifts its medium-term price outlook for iron ore, which should help Cliffs Natural Resources (<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+1.6%</font>), but the firm still thinks investors should not start buying shares, maintaining its <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/03/03/credit-suisse-bumps-up-cliffs-estimates-on-higher-iron-ore-prices/?mod=BOLBlog\" target=\"_blank\">Underperform rating</a> albeit with an improved $8 price target.</li><li>Credit Suisse now expects H1 iron ore prices of $92.50/metric ton, although it sees a downturn in H2 with a Q4 forecast of $55/metric ton.</li><li>The firm says CLF remains highly levered to seaborne iron ore prices and U.S. hot rolled coil, which is heavily influenced by iron ore prices due to scrap&rsquo;s substitutability with pig iron, and its shares are highly correlated with short-term movements in spot iron ore but should decouple somewhat as ore prices moderate.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248630\" data-linked=\"Cliffs outlook gets bump from Credit Suisse on higher iron ore prices\" data-tweet=\"$CLF - Cliffs outlook gets bump from Credit Suisse on higher iron ore prices https://seekingalpha.com/news/3248630-cliffs-outlook-gets-bump-from-credit-suisse-on-higher-iron-ore-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3248630-cliffs-outlook-gets-bump-from-credit-suisse-on-higher-iron-ore-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248629\" data-ts=\"1488572666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MET\" target=\"_blank\">MET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248629-groundhog-day-financials-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Groundhog day: Financials outperform</a></h4><ul><li>The major averages are flat, but the <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>, <a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> and <a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a> are all&nbsp;<font color='green'>higher by 0.5%</font>&nbsp;or more as yield-starved financials look forward to what's almost becoming the certainty of a Fed rate hike this month.</li><li>It's a remarkable turnaround in sentiment given we entered the week with futures markets pricing in just 25% chance of a Fed move in March. A series of Fed speakers, however - <a href=\"https://seekingalpha.com/news/3248598-yellen-march-rate-hike-coming\" target=\"_blank\">concluding with Janet Yellen today</a> - managed to turn those bets upside down. Sometimes the Fed does lead the market!</li><li>The largest gainer in the S&amp;P 500 today is MetLife (<a href='https://seekingalpha.com/symbol/MET' title='MetLife, Inc.'>MET</a> <font color='green'>+2.6%</font>). Prudential (<a href='https://seekingalpha.com/symbol/PRU' title='Prudential Financial, Inc.'>PRU</a> <font color='green'>+1%</font>), Lincoln National (<a href='https://seekingalpha.com/symbol/LNC' title='Lincoln National Corporation'>LNC</a> <font color='green'>+0.9%</font>)</li><li>Banks: Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='green'>+1.2%</font>), Morgan Stanley (<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color='green'>+1.5%</font>), KeyCorp (<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a> <font color='green'>+1.1%</font>), Synovus (<a href='https://seekingalpha.com/symbol/SNV' title='Synovus Financial Corp.'>SNV</a> <font color='green'>+1.3%</font>), Zions (<a href='https://seekingalpha.com/symbol/ZION' title='Zions Bancorporation'>ZION</a> <font color='green'>+1.2%</font>), Comerica (<a href='https://seekingalpha.com/symbol/CMA' title='Comerica Inc.'>CMA</a> <font color='green'>+1.2%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248629\" data-linked=\"Groundhog day: Financials outperform\" data-tweet=\"$MET $XLF $KBE - Groundhog day: Financials outperform https://seekingalpha.com/news/3248629-groundhog-day-financials-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3248629-groundhog-day-financials-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248624\" data-ts=\"1488571201\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248624-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ELON' title='Echelon Corporation'>ELON</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/IMMR' title='Immersion Corporation'>IMMR</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/MRIN' title='Marin Software'>MRIN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ICLD-OLD' title='InterCloud Systems, Inc.'>ICLD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248624\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$RNVA $SNAP $BITA - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3248624-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3248624-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248614\" data-ts=\"1488570147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPR\" target=\"_blank\">HPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248614-bill-barrettminus-10_5-following-disappointing-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bill Barrett -10.5% following disappointing Q4 results</a></h4><ul>     <li>Bill Barrett (BBG <font color='red'>-10.6%</font>) plunges more than 10% after reporting <a href=\"https://seekingalpha.com/news/3248318-bill-barrett-misses-0_05-misses-revenue\" target=\"_blank\">Q4 earnings</a> and revenues that trailed Wall Street expectations.</li>     <li>BBG expects capital spending of $255M-$285M in FY 2017, including the addition of a drilling rig during Q2 that it plans to fund with operating cash flow and cash on hand rather than tapping into its undrawn credit facility.</li><li>BBG forecasts 2017 production of 6M-6.5M boe, a 7% Y/Y increase at the midpoint after accounting for recent asset sales, which it says will translate into 30%-50% higher production in 2018, with a greater  increase in oil volumes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248614\" data-linked=\"Bill Barrett -10.5% following disappointing Q4 results\" data-tweet=\"$HPR - Bill Barrett -10.5% following disappointing Q4 results https://seekingalpha.com/news/3248614-bill-barrettminus-10_5-following-disappointing-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3248614-bill-barrettminus-10_5-following-disappointing-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248608\" data-ts=\"1488567724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248608-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ASIX' title='AdvanSix Inc.'>ASIX</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SNMX' title='Senomyx, Inc.'>SNMX</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='red'>-16%</font>. BBG <font color='red'>-11%</font>. URRE <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/VGZ' title='Vista Gold Corp.'>VGZ</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/UEC' title='Uranium Energy Corp'>UEC</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248608\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$ASIX $SNMX $ANW - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3248608-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3248608-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248599\" data-ts=\"1488564354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248599-snap-downgraded-to-underweight-atlantic-equities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap downgraded to Underweight at Atlantic Equities</a></h4><ul><li>From a <a href=\"https://seekingalpha.com/news/3244818-atlantic-equities-initiates-snap-neutral-14-target\" target=\"_blank\">Neutral view</a> initiated last week, <a href=\"http://www.streetinsider.com/Analyst+Comments/Atlantic+Equities+Downgrades+Snap+Inc+%28SNAP%29+to+Underweight/12625807.html\" target=\"_blank\">firm considers</a> present trade levels unsustainable given unproven monetization prospect, profitability that's structurally lower as compared to Facebook, and challenges Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) may face in significantly re-accelerating user growth. Price target unchanged at $14 (current price $26.82,&nbsp;<font color='green'>+9.56%</font>).</li><li>Previously &ndash;&nbsp;<a href=\"https://seekingalpha.com/news/3248506-susquehanna-initiates-snap-neutral-22-target\" target=\"_blank\">Susquehanna initiates Snap at Neutral, $22 target</a>&nbsp;(March 3) /&nbsp;<a href=\"https://seekingalpha.com/news/3248279-nomura-pivotal-research-negative-snap-amid-trading-debut\" target=\"_blank\">Nomura, Pivotal Research negative on Snap amid trading debut</a> (March 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248599\" data-linked=\"Snap downgraded to Underweight at Atlantic Equities\" data-tweet=\"$SNAP - Snap downgraded to Underweight at Atlantic Equities https://seekingalpha.com/news/3248599-snap-downgraded-to-underweight-atlantic-equities?source=tweet\" data-url=\"https://seekingalpha.com/news/3248599-snap-downgraded-to-underweight-atlantic-equities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248597\" data-ts=\"1488564029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248597-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EQS' title='Equus Total Return'>EQS</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francés S.A.  ADR'>BFR</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248597\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$EQS $BBAR $CARV - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3248597-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3248597-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248590\" data-ts=\"1488563615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMU\" target=\"_blank\">IMMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248590-immunomedics-perks-up-1-on-preliminary-shareholder-vote-backing-election-of-four-new\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immunomedics perks up 1% on preliminary shareholder vote backing the election of four new directors</a></h4><ul><li>The <a href=\"https://www.thestreet.com/story/14026332/1/activist-investor-wins-control-of-immunomedics-board-following-shareholder-vote.html\" target=\"_blank\">preliminary tally</a> of shareholder votes is in from Immunomedics' (<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+1.4%</font>) Annual Meeting, representing a showdown with venBio. The four directors supported by the activist investor are in.</li><li>VenBio also sought the removal of Chairman, Chief Scientific Officer and Chief Patent Officer David Goldenberg and his wife, CEO Cynthia Goldenberg.</li><li>The most contentious issue is the licensing deal with Seattle Genetics for cancer candidate IMMU-132, which venBio calls the \"crown jewel\" of its pipeline.</li><li>The reconstituted board will most likely initiate a search for a new CEO and either seek to cancel or at least renegotiate the SGEN deal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248590\" data-linked=\"Immunomedics perks up 1% on preliminary shareholder vote backing the election of four new directors\" data-tweet=\"$IMMU - Immunomedics perks up 1% on preliminary shareholder vote backing the election of four new directors https://seekingalpha.com/news/3248590-immunomedics-perks-up-1-on-preliminary-shareholder-vote-backing-election-of-four-new?source=tweet\" data-url=\"https://seekingalpha.com/news/3248590-immunomedics-perks-up-1-on-preliminary-shareholder-vote-backing-election-of-four-new\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248589\" data-ts=\"1488563449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEUGF\" target=\"_blank\">PEUGF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248589-psa-board-said-to-approve-opel-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PSA board said to approve Opel acquisition</a></h4><ul><li>The board at PSA Group (<a href='https://seekingalpha.com/symbol/PEUGF' title='Peugeot S.A.'>OTCPK:PEUGF</a>, <a href='https://seekingalpha.com/symbol/PUGOY' title='PEUGEOT SA UNSP/ADR'>OTCPK:PUGOY</a>, <a href='https://seekingalpha.com/symbol/PUGOF' title='Peugeot S.A.'>OTC:PUGOF</a>) has <a href=\"http://www.reuters.com/article/us-opel-m-a-idUSKBN16A240\" target=\"_blank\">approved</a> the company's purchase of Opel (NYSE:<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a>), according to Reuters.</li><li>A source indicates that an early announcement about a deal on Monday is anticipated.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3248399-opel-deal-happen-days\" target=\"_blank\">Opel deal could happen in days</a> (March 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248589\" data-linked=\"PSA board said to approve Opel acquisition\" data-tweet=\"$PEUGF $PEUGF $PUGOY - PSA board said to approve Opel acquisition https://seekingalpha.com/news/3248589-psa-board-said-to-approve-opel-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3248589-psa-board-said-to-approve-opel-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248588\" data-ts=\"1488563038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STKL\" target=\"_blank\">STKL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248588-sunopta-reverses-post-earnings-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunOpta reverses post-earnings slide</a></h4><ul>     <li>Shares of SunOpta (<a href='https://seekingalpha.com/symbol/STKL' title='SunOpta, Inc.'>STKL</a> <font color='green'>+14.8%</font>) come roaring back after a post-earnings swoon. Today's rally brings SunOpta back over $7, where it was before Q4 numbers were disclosed by the healthy products seller.</li>     <li>\"Longer-term, I think people believe in the co. in three to five years from now,\" Lake Street Capital tells Bloomberg.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3247558-sunopta-misses-0_13-misses-revenue\" target=\"_blank\">SunOpta misses by $0.13, misses on revenue</a> (March 1)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248588\" data-linked=\"SunOpta reverses post-earnings slide\" data-tweet=\"$STKL - SunOpta reverses post-earnings slide https://seekingalpha.com/news/3248588-sunopta-reverses-post-earnings-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/3248588-sunopta-reverses-post-earnings-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248587\" data-ts=\"1488562866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/E\" target=\"_blank\">E</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248587-eni-expects-to-discover-2bminus-3b-boe-over-next-four-years-even-lower-capex\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eni expects to discover 2B-3B boe over next four years even with lower capex</a></h4><ul><li>Eni (<a href='https://seekingalpha.com/symbol/E' title='ENI S.p.A.'>E</a> <font color='green'>+2.3%</font>) says it <a href=\"http://www.ogj.com/articles/2017/03/eni-expects-to-discover-2-3-billion-boe-over-next-4-years.html\" target=\"_blank\">expects to report 2B-3B boe in discoveries</a> over the next four years, nearly double the amount in its previous four-year plan, by drilling  ~120 wells in more than 20 countries.</li><li>Eni plans on the drilling despite an expected 10% reduction in exploration capital spending; overall capex in Eni&rsquo;s 2017-20 strategic plan is  expected to total &euro;31.6B.</li><li>Eni says its portfolio flexibility, the success of its ongoing  exploration strategy, synergies with existing assets, and contract  renegotiations will allow an average breakeven price of new projects of $30/bbl.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248587\" data-linked=\"Eni expects to discover 2B-3B boe over next four years even with lower capex\" data-tweet=\"$E - Eni expects to discover 2B-3B boe over next four years even with lower capex https://seekingalpha.com/news/3248587-eni-expects-to-discover-2bminus-3b-boe-over-next-four-years-even-lower-capex?source=tweet\" data-url=\"https://seekingalpha.com/news/3248587-eni-expects-to-discover-2bminus-3b-boe-over-next-four-years-even-lower-capex\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248586\" data-ts=\"1488562809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248586-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/BIOS' title='BioScrip, Inc.'>BIOS</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/DVCR' title='Diversicare Healthcare Services Inc.'>DVCR</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/AHPI' title='Allied Healthcare Products, Inc.'>AHPI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/HABT' title='The Habit Restaurants'>HABT</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/STKL' title='SunOpta, Inc.'>STKL</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/ADPT' title='Adeptus Health'>ADPT</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/IMMR' title='Immersion Corporation'>IMMR</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='red'>-12%</font>. URRE <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/VGZ' title='Vista Gold Corp.'>VGZ</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NAK' title='Northern Dynasty Minerals Ltd'>NAK</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NDLS' title='Noodles & Company'>NDLS</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248586\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$RNVA $EDSA $BIOS - Midday Gainers / Losers https://seekingalpha.com/news/3248586-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3248586-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248584\" data-ts=\"1488562439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNCR\" target=\"_blank\">SNCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248584-synchronoss-technologies-extends-losses-1_8-cautious-pacific-square-research-commentary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synchronoss Technologies extends losses 1.8%, cautious Pacific Square Research commentary reported</a></h4><ul><li>Reduced by&nbsp;<font color='red'>more than 12%</font>&nbsp;over the last week,&nbsp;<font color='red'>30%+</font>&nbsp;on the month and&nbsp;<font color='red'>45%+</font>&nbsp;over the prior three,&nbsp;Synchronoss Technologies is noted to have been mentioned warily <a href=\"http://www.streetinsider.com/Analyst+Comments/Pacific+Square+Research+Slams+Synchronoss+%28SNCR%29+in+Cautious+Report/12626856.html\" target=\"_blank\">by Pacific Square Research</a>, with concerns raised involving supposed balance sheet levering in order to acquire money-losing businesses and claimed efforts to conceal double-digit organic cloud declines.</li><li>Synchronoss Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a>) $26.59.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248584\" data-linked=\"Synchronoss Technologies extends losses 1.8%, cautious Pacific Square Research commentary reported\" data-tweet=\"$SNCR - Synchronoss Technologies extends losses 1.8%, cautious Pacific Square Research commentary reported https://seekingalpha.com/news/3248584-synchronoss-technologies-extends-losses-1_8-cautious-pacific-square-research-commentary?source=tweet\" data-url=\"https://seekingalpha.com/news/3248584-synchronoss-technologies-extends-losses-1_8-cautious-pacific-square-research-commentary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248578\" data-ts=\"1488560873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248578-pandora-extends-board-nomination-deadline-shares-up-2_9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora extends board nomination deadline; shares up 2.9%</a></h4><ul>   <li>Pandora (NYSE:<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a>) has <a href=\"https://seekingalpha.com/filing/3442435\" target=\"_blank\">extended its deadline</a> for nominations to the board, to March 17, amid increasing questions about whether a proxy fight is ahead.</li>    <li>That deadline was set to arrive today. Shares are <font color='green'>up 2.9%</font>.</li>    <li>BTIG's Rich Greenfield has figured that CEO and founder Tim Westergren could <a href=\"https://seekingalpha.com/news/3248382-btig-time-running-short-pandoras-westergren\" target=\"_blank\">lose his board seat</a> at the annual meeting, as it's one that's set for expiration on the company's staggered board.</li>    <li>Management needs to think about selling the company, Greenfield figures, after poor execution for some time. And Pandora has seen a revolving door of execs over the fall and winter, with Mike Herring giving up the CFO's role in November and COO Sara Clemens <a href=\"https://seekingalpha.com/news/3231851-pandoras-coo-exits-second-leadership-change-month\" target=\"_blank\">exiting that role</a> in December.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248578\" data-linked=\"Pandora extends board nomination deadline; shares up 2.9%\" data-tweet=\"$P - Pandora extends board nomination deadline; shares up 2.9% https://seekingalpha.com/news/3248578-pandora-extends-board-nomination-deadline-shares-up-2_9?source=tweet\" data-url=\"https://seekingalpha.com/news/3248578-pandora-extends-board-nomination-deadline-shares-up-2_9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248577\" data-ts=\"1488560676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248577-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/STKL' title='SunOpta, Inc.'>STKL</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corp.'>VOXX</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/THST' title='Truett-Hurst, Inc.'>THST</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International Inc.'>TPX</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248577\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$STKL $PME $VOXX - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3248577-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3248577-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248570\" data-ts=\"1488558731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANGI\" target=\"_blank\">ANGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248570-angies-list-gives-back-gains-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Angie&#39;s List gives back gains, down 5%</a></h4><ul>   <li>Angie's List (NASDAQ:<a href='https://seekingalpha.com/symbol/ANGI' title='ANGI Homeservices Inc.'>ANGI</a>) is back on the downside of a roller coaster today, <font color='red'>down 5%</font> after a mystery rally yesterday pushed the stock <font color='green'>up 6.2%</font>.</li>    <li>The company had no comment on the move up, which came on more than double average volume.</li>    <li>Volume is running healthy today with nearly 300,000 shares traded.</li>    <li>The stock had moved up premarket following <a href=\"https://seekingalpha.com/news/3243533-angies-list-plus-6_5-percent-premarket-q4-2016-eps-revenue-projections\" target=\"_blank\">earnings</a> on Feb. 15 but then declined 9% that day as the company missed on revenues.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248570\" data-linked=\"Angie&#39;s List gives back gains, down 5%\" data-tweet=\"$ANGI - Angie&#39;s List gives back gains, down 5% https://seekingalpha.com/news/3248570-angies-list-gives-back-gains-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3248570-angies-list-gives-back-gains-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248565\" data-ts=\"1488558002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCLR\" target=\"_blank\">OCLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248565-oclaroplus-5_4-piper-jaffray-reiterates-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oclaro +5.4%, Piper Jaffray reiterates Overweight</a></h4><ul><li>Maintaining $15 price target, <a href=\"http://www.streetinsider.com/Analyst+Comments/PiperJaffray+Says+Now+Is+The+Time+To+Revisit+Oclaro+%28OCLR%29/12626762.html\" target=\"_blank\">analyst Troy Jensen</a> observes several forthcoming catalysts for Oclaro, including a probable ZTE settlement, favorable industry commentary expected at the <a href=\"http://www.ofcconference.org/en-us/home/\" target=\"_blank\">OFC Conference</a>,&nbsp;as well as anticipated \"near flawless execution\" when Oclaro reports March-quarter figures. Further suggests limited downside given M&amp;A potential and considers recent inventory concerns to be overblown.</li><li>Oclaro (NASDAQ:<a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a>) $9.36.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248565\" data-linked=\"Oclaro +5.4%, Piper Jaffray reiterates Overweight\" data-tweet=\"$OCLR - Oclaro +5.4%, Piper Jaffray reiterates Overweight https://seekingalpha.com/news/3248565-oclaroplus-5_4-piper-jaffray-reiterates-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3248565-oclaroplus-5_4-piper-jaffray-reiterates-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248559\" data-ts=\"1488556235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSIC-OLD\" target=\"_blank\">FSIC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248559-day-2-of-post-earnings-losses-for-fs-investment-wells-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Day 2 of post-earnings losses for FS Investment; Wells downgrades</a></h4><ul><li>The company on Wednesday evening reported Q4 adjusted net investment income of $0.23 per share, up from $0.20 in Sept. and down one penny from a year ago. Consensus was for $0.25. The distribution is just under $0.23.</li><li>Dec. 31 NAV per share of $9.41 vs. $9.42 three months earlier and $9.10 a year ago. The $10.80 share price prior to earnings represented about a 15% premium to NAV.</li><li>CEO Michael Forman took note of tight credit markets forcing a conservative approach in Q4, with the company making purchases of $495.1M vs. sales and repayments of $715.6M.</li><li>Wells Fargo today cuts to Market Perform from Outperform.</li><li><a href='https://seekingalpha.com/symbol/FSIC-OLD' title='FS Investment Corporation'>FSIC-OLD</a><font color='red'> -2.2%</font>&nbsp;this session, and&nbsp;<font color='red'>more than 6%</font>&nbsp;since the results. Current price is $10.12.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247856-fs-investment-misses-0_02-misses-total-investment-income\" target=\"_blank\">FS Investment misses by $0.02, misses on total investment income</a> (March 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248559\" data-linked=\"Day 2 of post-earnings losses for FS Investment; Wells downgrades\" data-tweet=\"$FSIC-OLD - Day 2 of post-earnings losses for FS Investment; Wells downgrades https://seekingalpha.com/news/3248559-day-2-of-post-earnings-losses-for-fs-investment-wells-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3248559-day-2-of-post-earnings-losses-for-fs-investment-wells-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248558\" data-ts=\"1488555599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONCS\" target=\"_blank\">ONCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248558-thestreets-feuerstein-says-oncosec-may-be-nano-cap-worth-following\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TheStreet&#39;s Feuerstein says OncoSec may be a nano cap worth following</a></h4><ul><li>TheStreet's Adam Feuerstein <a href=\"https://www.thestreet.com/story/14024725/1/biotech-stock-mailbag-oncosec-medical-and-the-quest-to-turn-cold-tumors-hot.html\" target=\"_blank\">weighs in</a> on nano cap OnceSec Medical (<a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a> <font color='green'>+6.7%</font>) after its recently released positive results from a mid-stage study assessing ImmunoPulse IL-12 in melanoma patients not expected to respond to anti-PD-1 therapy. Shares have rallied ~40% on the news although still in the grips of a long-term downtrend.</li><li>Mr. Feuerstein has not deviated from his well-documented skepticism with tiny biotechs, but he says the trial results offer guarded optimism since there was one complete responder (ImmunoPulse IL-12 + Merck's Keytruda) in a group of nine participants who had been previously treated with a PD-1 inhibitor. One success could be an outlier and non-repeatable so more investigating needs to be done.</li><li>The company plans to initiate another Phase 2 study later this year in patients who have failed anti-PD-1 therapy alone. If successful, it will support a U.S. marketing application.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3245921-oncosecs-immunopulse-shows-treatment-effect-mid-stage-melanoma-study-shares-ahead-3-percent\" target=\"_blank\">OncoSec's ImmunoPulse shows treatment effect in mid-stage melanoma study; shares ahead 3%</a> (Feb. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248558\" data-linked=\"TheStreet&#39;s Feuerstein says OncoSec may be a nano cap worth following\" data-tweet=\"$ONCS - TheStreet&#39;s Feuerstein says OncoSec may be a nano cap worth following https://seekingalpha.com/news/3248558-thestreets-feuerstein-says-oncosec-may-be-nano-cap-worth-following?source=tweet\" data-url=\"https://seekingalpha.com/news/3248558-thestreets-feuerstein-says-oncosec-may-be-nano-cap-worth-following\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248557\" data-ts=\"1488555486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNNT\" target=\"_blank\">PNNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248557-efficient-markets-pennantpark-investmentminus-5-after-old-news-dividend-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Efficient markets? PennantPark Investment -5% after &#39;old news&#39; dividend cut</a></h4><ul><li>PennantPark Investment (<a href='https://seekingalpha.com/symbol/PNNT' title='PennantPark Investment'>PNNT</a> <font color='red'>-5%</font>) first announced <a href=\"https://seekingalpha.com/news/3226207-pennantpark-tumbles-rough-quarter-dividend-cut\" target=\"_blank\">its intention to cut the </a>quarterly dividend to $01.8 per share from $0.28 alongside its FQ4 earnings report on Nov. 21. It <a href=\"https://seekingalpha.com/news/3242359-pennantpark-investment-continues-run-inline-quarter-gain-nav\" target=\"_blank\">reiterated those plans</a> alongside its FQ1 report on Feb. 8.</li><li>Last night, it <a href=\"https://seekingalpha.com/news/3248349-pennantpark-investment-declares-0_18-dividend\" target=\"_blank\">officially declared </a>the $0.18 dividend payable on April 3, with ex-dividend date of March 20. Go figure.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248557\" data-linked=\"Efficient markets? PennantPark Investment -5% after &#39;old news&#39; dividend cut\" data-tweet=\"$PNNT - Efficient markets? PennantPark Investment -5% after &#39;old news&#39; dividend cut https://seekingalpha.com/news/3248557-efficient-markets-pennantpark-investmentminus-5-after-old-news-dividend-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3248557-efficient-markets-pennantpark-investmentminus-5-after-old-news-dividend-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248553\" data-ts=\"1488554955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVA\" target=\"_blank\">CVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248553-covantaminus-5-after-goldman-issues-sell-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Covanta -5% after Goldman issues Sell rating</a></h4><ul><li>Covanta (<a href='https://seekingalpha.com/symbol/CVA' title='Covanta Holding Corporation'>CVA</a> <font color='red'>-4.8%</font>) plunges as much as 7.4% after Goldman Sachs initiates coverage with a <a href=\"https://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Starts+Covanta+%28CVA%29+at+Sell/12625615.html\" target=\"_blank\">Sell rating</a> and a $12.50 price target, uneasy with CVA&rsquo;s increasing energy exposure to uncontracted market risk.</li><li>Goldman sees limited growth for the U.S. waste-to-energy market due to flattish  volumes, environmental concerns and challenged economics given lower  power prices and the cheap cost of landfilling.</li><li>The firm also notes uncertainty around CVA's earnings and free cash flow outlook following last month's fire at the Fairfax, Va., waste-to-energy facility.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248553\" data-linked=\"Covanta -5% after Goldman issues Sell rating\" data-tweet=\"$CVA - Covanta -5% after Goldman issues Sell rating https://seekingalpha.com/news/3248553-covantaminus-5-after-goldman-issues-sell-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3248553-covantaminus-5-after-goldman-issues-sell-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248547\" data-ts=\"1488553382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNKD\" target=\"_blank\">MNKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248547-post-split-trading-in-mannkind-commences-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-split trading in MannKind commences today</a></h4><ul><li>MannKind's (<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-12.6%</font>) 1:5 reverse split of its common shares was effective at 5:01 pm ET yesterday. Post-split trading starts today.</li><li>The company reduced the number of authorized shares in order to regain Nasdaq listing requirements. The stock continues to struggle, though. It has dropped about 20% since Wednesday and over 90% since 2015.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248547\" data-linked=\"Post-split trading in MannKind commences today\" data-tweet=\"$MNKD - Post-split trading in MannKind commences today https://seekingalpha.com/news/3248547-post-split-trading-in-mannkind-commences-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3248547-post-split-trading-in-mannkind-commences-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248543\" data-ts=\"1488552964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248543-ciena-downgraded-to-neutral-bank-of-america-merrill-lynchminus-2_1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ciena downgraded to Neutral at Bank of America Merrill Lynch; -2.1%</a></h4><ul><li>From Buy prior, analyst Tal Liani views upside limited given elevated expectations already reflected in valuation.</li><li>Target steady at $28. Ciena (NASDAQ:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) $25.83 (<font color='green'>+5%</font>&nbsp;on the month,&nbsp;<font color='green'>22%</font>&nbsp;over the prior three).</li></ul><div class=\"tiny-share-widget\" data-id=\"3248543\" data-linked=\"Ciena downgraded to Neutral at Bank of America Merrill Lynch; -2.1%\" data-tweet=\"$CIEN - Ciena downgraded to Neutral at Bank of America Merrill Lynch; -2.1% https://seekingalpha.com/news/3248543-ciena-downgraded-to-neutral-bank-of-america-merrill-lynchminus-2_1?source=tweet\" data-url=\"https://seekingalpha.com/news/3248543-ciena-downgraded-to-neutral-bank-of-america-merrill-lynchminus-2_1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248542\" data-ts=\"1488552960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAL\" target=\"_blank\">CAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248542-morgan-stanley-likes-upside-caleres\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley likes the upside with Caleres</a></h4><ul> <li>Caleres (<a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a> <font color='green'>+4.9%</font>) jets higher after Morgan Stanley <a href=\"https://www.benzinga.com/analyst-ratings/upgrades/17/03/9126358/benzingas-top-upgrades-downgrades-for-march-3-2017\" target=\"_blank\">upgrades</a> to Overweight from Equal-weight.</li> <li>The firm thinks the upside potential for the core Caleres business offsets Amazon risk and the soft macro backdrop.</li> <li>The price target is popped up to $37 from $44.</li> <li>Earlier, Caleres broke over $32 for the first time since early January. The 52-week high is $36.61.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248542\" data-linked=\"Morgan Stanley likes the upside with Caleres\" data-tweet=\"$CAL - Morgan Stanley likes the upside with Caleres https://seekingalpha.com/news/3248542-morgan-stanley-likes-upside-caleres?source=tweet\" data-url=\"https://seekingalpha.com/news/3248542-morgan-stanley-likes-upside-caleres\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248541\" data-ts=\"1488552710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248541-bounce-in-natural-gas-price-continues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bounce in natural gas price continues</a></h4><ul><li>This just in: Natural gas prices <a href=\"http://finviz.com/futures_charts.ashx?t=NG&amp;p=d1\" target=\"_blank\">are higher for an</a> eight consecutive day. Helping is a break in the spring-like weather in the Northeast, and though things are expected to warm up again next week, the forecast for mid-March suggests the heating season isn't over just yet.</li><li>The nattie is<font color='green'> up 0.3%</font>&nbsp;today to $2.8120 - still down from more than $4 at the start of the year.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3248541\" data-linked=\"Bounce in natural gas price continues\" data-tweet=\"$UNG $UGAZ $DGAZ - Bounce in natural gas price continues https://seekingalpha.com/news/3248541-bounce-in-natural-gas-price-continues?source=tweet\" data-url=\"https://seekingalpha.com/news/3248541-bounce-in-natural-gas-price-continues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248536\" data-ts=\"1488552005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DB\" target=\"_blank\">DB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248536-deutsche-bank-turns-lower-on-capital-raise-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank turns lower on capital raise chatter</a></h4><ul><li>Deutsche Bank (NYSE:<a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank AG'>DB</a>) had been in the green for most of today's session in Germany, but is now&nbsp;<font color='red'>lower by 1.75%</font>&nbsp;after Bloomberg says strategic options are to be reviewed over the coming weeks, among them a capital raise and partial sale of the asset management business.</li><li>The bank's supervisory board meets on March 16 and 17.</li><li>The ADRs are&nbsp;<font color='red'>down 0.6%</font>.</li><li>Update at 2:26 ET: Bloomberg further details this as a plan to raise $10.6B in capital through the sale of equity and part of the asset management unit.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248536\" data-linked=\"Deutsche Bank turns lower on capital raise chatter\" data-tweet=\"$DB - Deutsche Bank turns lower on capital raise chatter https://seekingalpha.com/news/3248536-deutsche-bank-turns-lower-on-capital-raise-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3248536-deutsche-bank-turns-lower-on-capital-raise-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248534\" data-ts=\"1488551830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTNX\" target=\"_blank\">NTNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248534-nutanix-downgraded-to-underweight-morgan-stanley-reiterated-buy-needham-and-company-amid-21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nutanix downgraded to Underweight at Morgan Stanley, reiterated Buy at Needham and Company amid 21% post-earnings decline [updated]</a></h4><ul><li>Reducing target from $29 to $20 and rating from Equal Weight (Bloomberg-sourced), analyst Katy Huberty (Morgan Stanley) <a href=\"http://www.streetinsider.com/Analyst+Comments/Morgan+Stanley+Downgrades+Nutanix+%28NTNX%29+to+Equalweight/12625611.html\" target=\"_blank\">projects near-term Nutanix trade</a>&nbsp;closer to firm's modified base case (vs. midpoint between base case and bull case) given market crowding (HPE/SimpliVity, Cisco HyperFlex cited)&nbsp;and removed possibility for new, sizable OEM partners, commodity-generated margin pressure, decelerating OEM growth, less large deals, greater Y/Y DSOs, shifts in U.S. sales force and forthcoming (March 28)&nbsp;lock-up expiry of approximately 84M shares.</li><li><a href=\"http://www.streetinsider.com/Analyst+Comments/Needham+and+Company+Maintains+Buy+Rating+and+%2436+PT+on+Nutanix+%28NTNX%29+Following+Record+F2Q+Results%2C+Lower+Guidance/12626141.html\" target=\"_blank\">Analyst Richard Kugele</a> (Needham &amp; Company), unmoved on rating and target ($36), considers issues impacting outlook immaterial longer-term. Further spotlights company's reiteration of plan to reach sustained free cash flow by year-end CY 2017.</li><li>Nutanix (NASDAQ:<a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a>) $24.66.</li><li>Yesterday (March 2, 2017): <a href=\"https://seekingalpha.com/news/3248344-nutanix-minus-15-percent-q2-2017-consensus-outlook\" target=\"_blank\">Nutanix -15%; Q2 2017 over consensus, outlook off</a>&nbsp;/ <a href=\"https://seekingalpha.com/article/4051723-nutanixs-sqbg-ceo-dheeraj-pandey-q2-2017-results-earnings-call-transcript\" target=\"_blank\">earnings call transcript</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3248534\" data-linked=\"Nutanix downgraded to Underweight at Morgan Stanley, reiterated Buy at Needham and Company amid 21% post-earnings decline [updated]\" data-tweet=\"$NTNX - Nutanix downgraded to Underweight at Morgan Stanley, reiterated Buy at Needham and Company amid 21% post-earnings decline [updated] https://seekingalpha.com/news/3248534-nutanix-downgraded-to-underweight-morgan-stanley-reiterated-buy-needham-and-company-amid-21?source=tweet\" data-url=\"https://seekingalpha.com/news/3248534-nutanix-downgraded-to-underweight-morgan-stanley-reiterated-buy-needham-and-company-amid-21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248523\" data-ts=\"1488550998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIFE\" target=\"_blank\">LIFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248523-ema-tags-atyrs-resolaris-orphan-drug-for-lgmd-shares-ahead-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EMA tags aTyr&#39;s Resolaris an Orphan Drug for LGMD; shares ahead 10% premarket</a></h4><ul><li>Thinly traded nano cap aTyr Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma'>LIFE</a>) is up&nbsp;<font color='green'>10%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16760673-atyr-pharma-receives-ema-orphan-drug-designation-treatment-limb-girdle-muscular-dystrophy\" target=\"_blank\">announcement </a>that the European Medicines Agency &#40;EMA&#41; has designated Resolaris an Orphan Drug for the treatment of limb girdle muscular dystrophy &#40;LGMD&#41;.</li><li>Among the benefits of Orphan Drug status in the EU is a 10-year period of market exclusivity for the indication, if approved.</li><li>The U.S. FDA tagged Resolaris an Orphan Drug for LGMD a few days ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247171-resolaris-orphan-drug-limb-girdle-muscular-dystrophy-atyr-19-percent\" target=\"_blank\">Resolaris an Orphan Drug for limb girdle muscular dystrophy; aTyr up 19%</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248523\" data-linked=\"EMA tags aTyr&#39;s Resolaris an Orphan Drug for LGMD; shares ahead 10% premarket\" data-tweet=\"$LIFE - EMA tags aTyr&#39;s Resolaris an Orphan Drug for LGMD; shares ahead 10% premarket https://seekingalpha.com/news/3248523-ema-tags-atyrs-resolaris-orphan-drug-for-lgmd-shares-ahead-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3248523-ema-tags-atyrs-resolaris-orphan-drug-for-lgmd-shares-ahead-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248519\" data-ts=\"1488550696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248519-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BIOS' title='BioScrip, Inc.'>BIOS</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/HABT' title='The Habit Restaurants'>HABT</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/GNC' title='GNC Holdings, Inc.'>GNC</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay'>VRAY</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma'>LIFE</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/OPGN' title='OpGen'>OPGN</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/IMMR' title='Immersion Corporation'>IMMR</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a> <font color='red'>-18%</font>. BBG <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3248519\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$BIOS $ONCS $HABT - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3248519-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3248519-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248516\" data-ts=\"1488550285\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTA\" target=\"_blank\">PRTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248516-prothena-prices-equity-offering-shares-down-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prothena prices equity offering; shares down 4% premarket</a></h4><ul><li>Prothena (NASDAQ:<a href='https://seekingalpha.com/symbol/PRTA' title='Prothena Corp plc'>PRTA</a>) eases&nbsp;<font color='red'>4%</font>&nbsp;premarket on light volume in response to the <a href=\"https://seekingalpha.com/pr/16760713-prothena-announces-pricing-public-offering-2700-000-ordinary-shares\" target=\"_blank\">pricing </a>of its public offering of 2.7M ordinary shares at $57.50. Underwriters over-allotment is an additional 405K shares. Closing date is March 8.</li><li>Yesterday's close was $60.07.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248516\" data-linked=\"Prothena prices equity offering; shares down 4% premarket\" data-tweet=\"$PRTA - Prothena prices equity offering; shares down 4% premarket https://seekingalpha.com/news/3248516-prothena-prices-equity-offering-shares-down-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3248516-prothena-prices-equity-offering-shares-down-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248506\" data-ts=\"1488549355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248506-susquehanna-initiates-snap-neutral-22-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna initiates Snap at Neutral, $22 target</a></h4><ul><li>Considering near-term detachment between valuation and fundamentals, <a href=\"http://www.streetinsider.com/Analyst+Comments/Susquehanna+Starts+Snap+Inc+%28SNAP%29+at+Neutral%2C+%2422+PT/12626128.html\" target=\"_blank\">analyst Shyam Patil</a> notes strong early interest in Snap may elevate shares into the high-$20s to low-$30s, though as a longer-term investment, struggles to assess meaningful upside beyond present range, specifically citing competitive pressures, most distinctly from Facebook, despite a signifiant total addressable market.</li><li>Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>)&nbsp;$25.37,&nbsp;<font color='green'>+3.64%</font>&nbsp;pre-market.</li><li>Yesterday (March 2, 2017):&nbsp;<a href=\"https://seekingalpha.com/news/3248279-nomura-pivotal-research-negative-snap-amid-trading-debut\" target=\"_blank\">Nomura, Pivotal Research negative on Snap amid trading debut</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3248506\" data-linked=\"Susquehanna initiates Snap at Neutral, $22 target\" data-tweet=\"$SNAP - Susquehanna initiates Snap at Neutral, $22 target https://seekingalpha.com/news/3248506-susquehanna-initiates-snap-neutral-22-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3248506-susquehanna-initiates-snap-neutral-22-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248502\" data-ts=\"1488548965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KKR\" target=\"_blank\">KKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248502-gnc-perks-up-8-on-kkr-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GNC perks up 8% on KKR interest</a></h4><ul><li>According to Dealreporter, <a href='https://seekingalpha.com/symbol/KKR' title='KKR'>KKR</a> has been in contact with SinoPharm and Fosun about a possible deal for <a href='https://seekingalpha.com/symbol/GNC' title='GNC Holdings, Inc.'>GNC</a>.</li><li>Shares&nbsp;<font color='green'>+8%</font>&nbsp;premarket</li><li>Previously: <a href=\"https://seekingalpha.com/news/3214835-acquisition-chatter-lifts-gnc-premarket-action\" target=\"_blank\">Acquisition chatter lifts GNC in premarket action</a> (Oct. 19, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248502\" data-linked=\"GNC perks up 8% on KKR interest\" data-tweet=\"$KKR $KKR $GNC - GNC perks up 8% on KKR interest https://seekingalpha.com/news/3248502-gnc-perks-up-8-on-kkr-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3248502-gnc-perks-up-8-on-kkr-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248497\" data-ts=\"1488548458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMSY\" target=\"_blank\">HMSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248497-hms-holdings-to-delay-filing-annual-report-due-to-possible-material-weakness-shares-slump-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HMS Holdings to delay filing annual report due to possible material weakness; shares slump 9% premarket</a></h4><ul><li>HMS Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/HMSY' title='HMS Holdings Corp'>HMSY</a>) is down&nbsp;<font color='red'>9%</font>&nbsp;premarket on light volume in response to the news that it will delay the filing of its 2016 10-K &nbsp;due to a potential material weakness in its internal controls over its financial reporting.</li><li>According to <a href=\"https://www.streetinsider.com/Corporate+News/HMS+Holdings+Corp.+%28HMSY%29+to+Delay+10K+Due+to+Possible+Material+Weakness+in+Internal+Controls/12624622.html\" target=\"_blank\">StreetInsider</a>, the company needs additional time to complete documentation related to its previously disclosed review of CMS reserves and related internal controls over reporting after its auditor identified a potential material weakness. The company has yet to complete is its assessment of the effectiveness of its internal controls over financial reporting and is continuing to evaluate whether the issue affects its financial results (primarily prior periods where CMS-related revenue was recorded).</li><li>HMS plans to file the 10-K no later than 15 days after the due date.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248497\" data-linked=\"HMS Holdings to delay filing annual report due to possible material weakness; shares slump 9% premarket\" data-tweet=\"$HMSY - HMS Holdings to delay filing annual report due to possible material weakness; shares slump 9% premarket https://seekingalpha.com/news/3248497-hms-holdings-to-delay-filing-annual-report-due-to-possible-material-weakness-shares-slump-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3248497-hms-holdings-to-delay-filing-annual-report-due-to-possible-material-weakness-shares-slump-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248490\" data-ts=\"1488547560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPE\" target=\"_blank\">EXPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248490-citi-no-longer-negative-on-expedia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi no longer negative on Expedia</a></h4><ul> <li>Shares of Expedia (NASDAQ:<a href='https://seekingalpha.com/symbol/EXPE' title='Expedia, Inc.'>EXPE</a>) are slightly higher in early trading after Citi <a href=\"http://www.cnbc.com/2017/03/03/early-movers-cost-big-expe-gpro-dps-adsk-more.html\" target=\"_blank\">pulls</a> its Sell rating on the online travel stock.</li> <li>Citi moves to a Neutral rating on renewed confidence that Expedia can expand its hotel business.</li> <li>EXPE <font color='green'>+0.51%</font> premarket to $119.53 vs. a 52-week trading range of $96.58 to $133.55.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3248490\" data-linked=\"Citi no longer negative on Expedia\" data-tweet=\"$EXPE - Citi no longer negative on Expedia https://seekingalpha.com/news/3248490-citi-no-longer-negative-on-expedia?source=tweet\" data-url=\"https://seekingalpha.com/news/3248490-citi-no-longer-negative-on-expedia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248487\" data-ts=\"1488547308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HABT\" target=\"_blank\">HABT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248487-habit-restaurantsplus-15-after-solid-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Habit Restaurants +15% after solid earnings</a></h4><ul> <li>Habit Restaurants (NASDAQ:<a href='https://seekingalpha.com/symbol/HABT' title='The Habit Restaurants'>HABT</a>) races higher after Q4 results top estimates.</li>  <li>Comparable restaurant sales at company-owned outlets was up 1.7% Y/Y during the quarter. A 2.2% gain in average transaction offset a 0.5% dip in customer transactions.</li> <li>Labor costs as a percentage of sales rose 180 bps to 33.4%. Food and paper costs fell 210 bps to 29.4% of sales. Total operating expenses fell 80 bps to 96.3% of sales.</li> <li>The company sees FY17 revenue of $338M to $342M vs. $339M consensus. Unit growth of 31 to 33 company-owned restaurants is anticipated for the year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3248303-habit-restaurants-beats-0_04-beats-revenue\" target=\"_blank\">The Habit Restaurants beats by $0.04, beats on revenue</a> (March 2)</li> <li>HABT <font color='green'>+15.22%</font> premarket to $15.90 vs. a 52-week trading range of $13.20 to $21.79.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248487\" data-linked=\"Habit Restaurants +15% after solid earnings\" data-tweet=\"$HABT - Habit Restaurants +15% after solid earnings https://seekingalpha.com/news/3248487-habit-restaurantsplus-15-after-solid-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3248487-habit-restaurantsplus-15-after-solid-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248462\" data-ts=\"1488545582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REV\" target=\"_blank\">REV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248462-on-revlons-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Revlon&#39;s Q4</a></h4><ul>     <li>Revlon (NYSE:<a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a>) reports pro forma net sales fell 2.7%&nbsp;if the impact of the currency swings is backed out in <a href=\"https://seekingalpha.com/pr/16760623-revlon-reports-2016-net-sales-growth-across-segments-raises-accelerates-acquisition-synergy\" target=\"_blank\">Q4</a>.</li>     <li>Consumer segment net sales slipped 5.2% to $367.5M primarily as a result of lower net sales of Revlon color cosmetics and Almay color cosmetics in the&nbsp;U.S.</li>     <li>Professional segment net sales rose 0.3% to $119.3M primarily due to higher net sales of American Crew men&rsquo;s grooming products and Revlon Professional hair products.</li>     <li>Elizabeth Arden net sales down 3.1% to $306.2M, driven by decreased net sales of celebrity and designer fragrances.</li>     <li>Pro forma adjusted EBITDA increased 1.1% to $149.4M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248462\" data-linked=\"More on Revlon&#39;s Q4\" data-tweet=\"$REV - More on Revlon&#39;s Q4 https://seekingalpha.com/news/3248462-on-revlons-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3248462-on-revlons-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248449\" data-ts=\"1488543788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248449-goprominus-1_5-citi-starts-coverage-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoPro -1.5%; Citi starts coverage with a Sell</a></h4><ul><li>\"The best house in a deteriorating neighborhood,\" GoPro's (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a>) market-leading products aren't enough to offset the overall decline in standalone imaging products and increased saturation in mature markets, says Citi's Stanley Kovler, initiating with a Sell rating and $8 price target (<font color='red'>14% downside&nbsp;</font>from yesterday's close).</li><li>Source: Bloomberg</li><li>Shares&nbsp;<font color='red'>-1.5%</font>&nbsp;premarket to $9.13.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248449\" data-linked=\"GoPro -1.5%; Citi starts coverage with a Sell\" data-tweet=\"$GPRO - GoPro -1.5%; Citi starts coverage with a Sell https://seekingalpha.com/news/3248449-goprominus-1_5-citi-starts-coverage-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3248449-goprominus-1_5-citi-starts-coverage-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248429\" data-ts=\"1488542490\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248429-lexicon-pharmaceuticals-beats-0_21-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon Pharmaceuticals beats by $0.21, beats on revenue</a></h4><ul><li>Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>): Q4 EPS of -$0.31 <font color='green'>beats by $0.21</font>.</li><li>Revenue of $23.04M (-81.9% Y/Y) <font color='green'>beats by $7.4M</font>.</li><li><a href=\"https://seekingalpha.com/pr/16760598-lexicon-pharmaceuticals-provides-clinical-pipeline-update-reports-2016-fourth-quarter-full\" target=\"_blank\">Press Release</a></li><li><strong>Update</strong>: Shares are up&nbsp;<font color='green'>5%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248429\" data-linked=\"Lexicon Pharmaceuticals beats by $0.21, beats on revenue\" data-tweet=\"$LXRX - Lexicon Pharmaceuticals beats by $0.21, beats on revenue https://seekingalpha.com/news/3248429-lexicon-pharmaceuticals-beats-0_21-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3248429-lexicon-pharmaceuticals-beats-0_21-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248418\" data-ts=\"1488540498\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIG\" target=\"_blank\">BIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248418-on-big-lots-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Big Lots Q4</a></h4><ul>     <li>Big Lots (NYSE:<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a>) reports comparable-store sales rose 0.3% in <a href=\"https://seekingalpha.com/pr/16760563-big-lots-reports-q4-eps-continuing-operations-1_99-2_26-adjusted-basis-previously\" target=\"_blank\">Q4</a>.</li>     <li>Gross margin rate improved 50 bps to 41.4%.</li>     <li>Adjusted SG&amp;A expense rate grew 40 bps to 29.1%.</li>     <li>Adjusted operating margin rate increased 10 bps to 10.4%.</li>     <li>Inventory +1% Y/Y to $859M.</li>     <li><b>Q1 Guidanc</b>e:&nbsp;Comparable-store sales:&nbsp;flat to +2% Y/Y;&nbsp;Adjusted&nbsp;EPS: $0.95 to $1.05 (+16% to +28%).</li>     <li><b>FY2017 Guidance</b>: Total sales:&nbsp;flat to up slightly&nbsp;Y/Y; Comparable-store sales: +1% to +2%; Adjusted&nbsp;EPS:&nbsp;$3.95 to $4.10 (+9% to +13%); Cash flow: ~$180M to $190M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248418\" data-linked=\"More on Big Lots Q4\" data-tweet=\"$BIG - More on Big Lots Q4 https://seekingalpha.com/news/3248418-on-big-lots-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3248418-on-big-lots-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248400\" data-ts=\"1488532895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOBC\" target=\"_blank\">AOBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248400-firearm-maker-shares-dip-demand-slows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Firearm maker shares dip as demand slows</a></h4><ul><li>Gunmaker shares declined in extended trade on Thursday after American Outdoor Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>), formerly known as Smith &amp; Wesson, <a href=\"https://seekingalpha.com/news/3248301-american-outdoor-brands-beats-0_11-misses-revenue\" target=\"_blank\">reported</a> FQ3 sales that were weaker than expected and said the gun business has slowed after unusual demand.</li><li>\"Toward the end of the quarter, consumer firearm purchasing began to cool,\" <a href=\"http://www.cnbc.com/2017/03/02/after-hours-buzz-aobc-ntnx-cost.html\" target=\"_blank\">said</a> James Debney, American Outdoor Brands' President and CEO.</li><li>After-hours: AOBC <font color='red'>-7.5%</font>; <a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company Inc.'>RGR</a> <font color='red'>-1.7%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3248400\" data-linked=\"Firearm maker shares dip as demand slows\" data-tweet=\"$AOBC $AOBC $RGR - Firearm maker shares dip as demand slows https://seekingalpha.com/news/3248400-firearm-maker-shares-dip-demand-slows?source=tweet\" data-url=\"https://seekingalpha.com/news/3248400-firearm-maker-shares-dip-demand-slows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":50,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}